Press Resease

Brain Tumor Diagnosis and Treatment Market - Global Industry Analysis

Brain Tumor Diagnosis and Treatment Market by Product (Primary Brain Tumor and Secondary Brain Tumor), by Diagnosis Type (CT Scan, MRI, PET-CT Scan, Molecular Testing, EEG, and Others), and by Treatment Type (Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, and Immunotherapy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024

Published Date: 26-Oct-2018 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3468 Status : Published

Global brain tumor diagnosis and treatment market expected to generate revenue of around USD 744 million by the end of 2024, growing at a CAGR of around 8.65% between 2018 and 2024. Brain tumors generally occur in supportive brain tissues. The exact cause of brain tumor is not yet known, and it can occur in any age group.

Description

The report covers the forecast and analysis of the brain tumor diagnosis and treatment market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes the drivers and restraints for the brain tumor diagnosis and treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the brain tumor diagnosis and treatment market on a global level.

In order to give the users of this report a comprehensive view of the brain tumor diagnosis and treatment market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Brain Tumor Diagnosis and Treatment Market

The report provides company market share analysis in order to give a broader overview of the key market players. In addition, the report also covers the key strategic developments of the market including acquisitions and mergers, new service diagnosis type launch, agreements, partnerships, collaborations, and joint ventures, research and development, service diagnosis type, and regional expansion of major participants involved in the market.

The study provides a decisive view on the brain tumor diagnosis and treatment market by segmenting it on the product, diagnosis type, treatment type, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further categorization into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes the demand for brain tumor diagnosis and treatment market based on all the segments in all the regions and countries.

The key players in the global brain tumor diagnosis and treatment market are GE Healthcare, AstraZeneca, Carestream Health, Pfizer, Inc., Merck & Co. Inc., Siemens Healthineers, Hitachi Medical Corporation, Philips Healthcare, Toshiba Medical Systems Corporation, and Shimadzu Corporation.

This report segments the global brain tumor diagnosis and treatment market as follows:

Global Brain Tumor Diagnosis and Treatment Market: Product Segment Analysis

  • Primary Brain Tumor
    • Meningioma
    • Gliomas
    • Astrocytomas
    • Pituitary Tumors
    • Other Primary Brain Tumors
  • Secondary Brain Tumor

Global Brain Tumor Diagnosis and Treatment Market: Diagnosis Type Segment Analysis

  • CT Scan
  • MRI
  • PET-CT Scan
  • Molecular Testing
  • EEG
  • Others

Global Brain Tumor Diagnosis and Treatment Market: Treatment Type Segment Analysis

  • Surgery
  • Radiation Therapy
  • Targeted Therapy
  • Chemotherapy
  • Immunotherapy

Global Brain Tumor Diagnosis and Treatment Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global brain tumor diagnosis and treatment market, 2015 - 2024 (USD Million)
    • 2.2. Global brain tumor diagnosis and treatment market: Snapshot
  •  
  • Chapter 3. Brain Tumor Diagnosis and Treatment Market - Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global brain tumor diagnosis and treatment market drivers: Impact analysis
      • 3.2.2. Rising incidences of neurological disorders
      • 3.2.3. Presence of the geriatric population
      • 3.2.4. Advancement in diagnostics techniques
      • 3.2.5. Innovations in drug delivery to brain cells
    • 3.3. Market Restraints
      • 3.3.1. Global brain tumor diagnosis and treatment market restraints: Impact analysis
      • 3.3.2. The high cost of brain tumor diagnosis and treatments
      • 3.3.3. Restricted Expansion in emerging countries
    • 3.4. Opportunities
      • 3.4.1. Development of technologically advanced products
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product segment
      • 3.6.2. Market attractiveness analysis, by diagnosis type segment
      • 3.6.3. Market attractiveness analysis, by treatment type segment
      • 3.6.4. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Brain Tumor Diagnosis and Treatment Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global brain tumor diagnosis and treatment market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New treatment type launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Brain Tumor Diagnosis and Treatment Market -Diagnosis Type Segment Analysis
    • 5.1. Global brain tumor diagnosis and treatment market: Diagnosis Type overview
      • 5.1.1. Global brain tumor diagnosis and treatment market revenue share, by diagnosis type, 2017 and 2024
    • 5.2. Primary Brain Tumor
      • 5.2.1. Global brain tumor diagnosis and treatment market for primary brain tumor, 2015 - 2024 (USD Million)
    • 5.3. Secondary Brain Tumor
      • 5.3.1. Global brain tumor diagnosis and treatment market for secondary brain tumor, 2015 - 2024 (USD Million)
  •  
  • Chapter 6. Global Brain Tumor Diagnosis and Treatment Market -Diagnosis Type Segment Analysis
    • 6.1. Global brain tumor diagnosis and treatment market: Diagnosis Type overview
      • 6.1.1. Global brain tumor diagnosis and treatment market revenue share, by diagnosis type, 2017 and 2024
    • 6.2. CT Scan
      • 6.2.1. Global brain tumor diagnosis and treatment market for bare metal stents, 2015 - 2024 (USD Million)
    • 6.3. MRI
      • 6.3.1. Global brain tumor diagnosis and treatment market for drug-eluting stents, 2015 - 2024 (USD Million)
    • 6.4. PET-CT Scan
      • 6.4.1. Global brain tumor diagnosis and treatment market for PET-CT scan, 2015 - 2024 (USD Million)
    • 6.5. Molecular Testing
      • 6.5.1. Global brain tumor diagnosis and treatment market for molecular testing, 2015 - 2024 (USD Million)
    • 6.6. EEG
      • 6.6.1. Global brain tumor diagnosis and treatment market for EEG, 2015 - 2024 (USD Million)
    • 6.7. Others
      • 6.7.1. Global brain tumor diagnosis and treatment market for others, 2015 - 2024 (USD Million)
  •  
  • Chapter 7. Global Brain Tumor Diagnosis and Treatment Market -Treatment Type Segment Analysis
    • 7.1. Global brain tumor diagnosis and treatment market: Treatment Type overview
      • 7.1.1. Global brain tumor diagnosis and treatment market revenue share, by treatment type, 2017 and 2024
    • 7.2. Surgery
      • 7.2.1. Global brain tumor diagnosis and treatment market for metallic stents, 2015 - 2024 (USD Million)
    • 7.3. Radiation Therapy
      • 7.3.1. Global brain tumor diagnosis and treatment market for radiation therapy, 2015 - 2024 (USD Million)
    • 7.4. Targeted Therapy
      • 7.4.1. Global brain tumor diagnosis and treatment market for targeted therapy, 2015 - 2024 (USD Million)
    • 7.5. Chemotherapy
      • 7.5.1. Global brain tumor diagnosis and treatment market for cardiac centers, 2015 - 2024 (USD Million)
    • 7.6. Immunotherapy
      • 7.6.1. Global brain tumor diagnosis and treatment market for Immunotherapy, 2015 - 2024 (USD Million)
  •  
  • Chapter 8. Global Brain Tumor Diagnosis and Treatment Market - Regional Segment Analysis
    • 8.1. Global brain tumor diagnosis and treatment market: Regional overview
      • 8.1.1. Global brain tumor diagnosis and treatment market revenue share, by region, 2017 and 2024
    • 8.2. North America
      • 8.2.1. North America brain tumor diagnosis and treatment market, 2015 - 2024 (USD Million)
      • 8.2.2. North America brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
      • 8.2.2.1. North America brain tumor diagnosis and treatment market revenue, by primary brain tumor, 2015 - 2024 (USD Million)
      • 8.2.3. North America brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
      • 8.2.4. North America brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
          • 8.2.5.1.1. The U.S. brain tumor diagnosis and treatment market revenue, by primary brain tumor, 2015 - 2024 (USD Million)
        • 8.2.5.2. The U.S. brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
        • 8.2.5.3. The U.S. brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
      • 8.2.6. Canada
        • 8.2.6.1. Canada brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
          • 8.2.6.1.1. Canada brain tumor diagnosis and treatment market revenue, by primary brain tumor, 2015 - 2024 (USD Million)
        • 8.2.6.2. Canada brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
        • 8.2.6.3. Canada brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe brain tumor diagnosis and treatment market, 2015 - 2024 (USD Million)
      • 8.3.2. Europe brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
        • 8.3.2.1. Europe brain tumor diagnosis and treatment market revenue, by primary brain tumor, 2015 - 2024 (USD Million)
      • 8.3.3. Europe brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
      • 8.3.4. Europe brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
      • 8.3.5. UK
        • 8.3.5.1. UK brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
          • 8.3.5.1.1. UK brain tumor diagnosis and treatment market revenue, by primary brain tumor, 2015 - 2024 (USD Million)
        • 8.3.5.2. UK brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
        • 8.3.5.3. UK brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
      • 8.3.6. Germany
        • 8.3.6.1. Germany brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
          • 8.3.6.1.1. Germany brain tumor diagnosis and treatment market revenue, by primary brain tumor, 2015 - 2024 (USD Million)
        • 8.3.6.2. Germany brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
        • 8.3.6.3. Germany brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
      • 8.3.7. France
        • 8.3.7.1. France brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
          • 8.3.7.1.1. France brain tumor diagnosis and treatment market revenue, by primary brain tumor, 2015 - 2024 (USD Million)
        • 8.3.7.2. France brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
        • 8.3.7.3. France brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
          • 8.3.8.1.1. Rest of Europe brain tumor diagnosis and treatment market revenue, by primary brain tumor, 2015 - 2024 (USD Million)
        • 8.3.8.2. Rest of Europe brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
        • 8.3.8.3. Rest of Europe brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific brain tumor diagnosis and treatment market, 2015 - 2024 (USD Million)
      • 8.4.2. Asia Pacific brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
        • 8.4.2.1. Asia Pacific brain tumor diagnosis and treatment market revenue, by primary brain tumor, 2015 - 2024 (USD Million)
      • 8.4.3. Asia Pacific brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
      • 8.4.4. Asia Pacific brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
          • 8.4.5.1.1. China brain tumor diagnosis and treatment market revenue, by primary brain tumor, 2015 - 2024 (USD Million)
        • 8.4.5.2. China brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
        • 8.4.5.3. China brain tumor diagnosis and treatment market revenue, by mode of delivery, 2015 - 2024 (USD Million)
        • 8.4.5.4. China brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
          • 8.4.6.1.1. Japan brain tumor diagnosis and treatment market revenue, by primary brain tumor, 2015 - 2024 (USD Million)
        • 8.4.6.2. Japan brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
        • 8.4.6.3. Japan brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
          • 8.4.7.1.1. India brain tumor diagnosis and treatment market revenue, by primary brain tumor, 2015 - 2024 (USD Million)
        • 8.4.7.2. India brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
        • 8.4.7.3. India brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
          • 8.4.8.1.1. Rest of Asia Pacific brain tumor diagnosis and treatment market revenue, by primary brain tumor, 2015 - 2024 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America brain tumor diagnosis and treatment market, 2015 - 2024 (USD Million)
      • 8.5.2. Latin America brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
        • 8.5.2.1. Latin America brain tumor diagnosis and treatment market revenue, by primary brain tumor, 2015 - 2024 (USD Million)
      • 8.5.3. Latin America brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
      • 8.5.4. Latin America brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
          • 8.5.5.1.1. Brazil brain tumor diagnosis and treatment market revenue, by a primary brain tumor, 2015 - 2024 (USD Million)
        • 8.5.5.2. Brazil brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
        • 8.5.5.3. Brazil brain tumor diagnosis and treatment market revenue, by mode of delivery, 2015 - 2024 (USD Million)
        • 8.5.5.4. Brazil brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
          • 8.5.6.1.1. Rest of Latin America brain tumor diagnosis and treatment market revenue, by a primary brain tumor, 2015 - 2024 (USD Million)
        • 8.5.6.2. Rest of Latin America brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
        • 8.5.6.3. Rest of Latin America brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa brain tumor diagnosis and treatment market, 2015 - 2024 (USD Million)
      • 8.6.2. The Middle East and Africa brain tumor diagnosis and treatment market revenue, by product, 2015 - 2024 (USD Million)
        • 8.6.2.1. The Middle East and Africa brain tumor diagnosis and treatment market revenue, by a primary brain tumor, 2015 - 2024 (USD Million)
      • 8.6.3. The Middle East and Africa brain tumor diagnosis and treatment market revenue, by diagnosis type, 2015 - 2024 (USD Million)
      • 8.6.4. The Middle East and Africa brain tumor diagnosis and treatment market revenue, by treatment type, 2015 - 2024 (USD Million)
  •  
  • Chapter 9. Company Profile
    • 9.1. GE Healthcare
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. AstraZeneca
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Merck & Co. Inc.
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Carestream Health
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Pfizer, Inc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. Siemens Healthineers
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. Hitachi Medical Corporation
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Philips Healthcare
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Toshiba Medical Systems Corporation
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. Shimadzu Corporation
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments

Methodology

Free Analysis

The brain is the most important organ of the human body, which consists of nerve cells and other supportive tissues. The development of cancerous cells in the brain is known as a brain tumor. There are two major types of brain tumor, namely secondary brain tumor and primary brain tumor. Primary brain tumors can either be malignant or benign, whereas secondary brain tumors are metastatic, i.e., they can spread to other organs as well.

According to CBTRUS (Central Brain Tumor Registry of the United States), in 2016, 80,000 new cases of nonmalignant, primary malignant, and CNS cancers were anticipated to be diagnosed in the U.S. in 2017. The rising incidence of brain tumor among the population is primarily fueling the growth of the global market for brain tumor diagnosis and treatment. The increasing geriatric population, development in diagnostics and treatment equipment, and ongoing research in the development of new technologies to treat cancers are anticipated to fuel the growth of the global brain tumor diagnosis and treatment market in the near future.

Global Brain Tumor Diagnosis and Treatment Market

The brain tumor diagnosis and treatment market are segmented based on product type, diagnosis type, and treatment type. Based on product type, the market for brain tumor diagnosis and treatment is bifurcated into primary brain tumor and secondary brain tumor. Primary brain tumors are further sub-segmented into gliomas, meningioma, pituitary tumors, astrocytomas, and other primary brain tumors. The primary brain tumor segment is anticipated to dominate the market during the forecast period, owing to the increase in the occurrences of meningioma cancer. Based on diagnosis type, this market is classified into MRI, CT scan, PET-CT scan, EEG, molecular testing, and others. The CT scan segment is anticipated to lead the diagnosis type segment for this market. The treatment type segment of the brain tumor diagnosis and treatment market includes chemotherapy, radiation therapy, targeted therapy, surgery, and immunotherapy. The surgery segment is estimated to dominate the brain tumor diagnosis and treatment market during the forecast period.

North America is projected to dominate the market during the forecast period, due to a rapid increase in research related to the development of techniques to treat brain tumor and increase in awareness about the treatments and management of brain tumor among the population. Europe is expected to show the highest growth owing to the rise in government initiatives, an increase in the prevalence of brain tumors in countries like the UK, and the growth of the geriatric population. Additionally, the growing awareness about brain tumor treatments and an increase in the investments made by companies are other factors fueling the growth of the brain tumor diagnosis and treatment market.

The main players in the brain tumor diagnosis and treatment market are GE Healthcare, Merck & Co. Inc., AstraZeneca, Hitachi Medical Corporation, Carestream Health, Pfizer, Inc., Siemens Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation, and Shimadzu Corporation. These companies focus on entering agreements and partnership to develop products and provide quality products. For instance, in 2016, Pfizer Inc. acquired Medivation, a company which is involved in the development of drugs used for treating cancer.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social